Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Short Communication Volume 4 Issue 11

Pandemic and Modern Medicine: Time to Recognize and Correct Previous Misconceptions

Igor Klepikov*

MD, Professor, Retired, USA

*Corresponding Author: Igor Klepikov, MD, Professor, Retired, USA..

Received: September 24, 2020; Published: October 07, 2020

×

   A year ago, few people doubted the scientific validity and practical feasibility of existing approaches to the treatment of acute pneumonia (AP). Even the use of a single antibiotic as the main treatment for completely different and disparate diseases was a common situation, the contradiction of which to the basics of clinical medicine was not questioned. The activity of antibiotics only against bacterial pathogens without additional effects on other manifestations of the disease did not prevent them from achieving the image of an almost panacea.

×

References

  1. JP Metlay., et al. “Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America”. American Journal of Respiratory and Critical Care Medicine7 (2019): e45-e67.
  2. Zhe Xu., et al. “Pathological findings of COVID-19 associated with acute respiratory distress syndrome”. The Lancet Respiratory Medicine4 (2020): 420-422.
  3. M Ackermann., et al. “Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 (2020).
  4. Lipman M., et al. “SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research”. Thorax 75 (2020): 614-616.
  5. Ruuskanen O., et al. “Viral pneumonia". Lancet9773 (2011): 1264-1275.
  6. Lodha R., et al. “Antibiotics for community-acquired pneumonia in children". The Cochrane Database of Systematic Reviews6 (2013): CD004874.
  7. Mayank Vats., et al. “Second Wave of COVID-19 - Could it be More Lethal!!! - Novel 6 T’s Strategies May Help”. EC Pulmonology and Respiratory Medicine8 (2020): 17-21.
  8. DA Berlin., et al. “Severe Covid-19”. The New England Journal of Medicine (2020).
  9. Rawson TM., et al. “Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing”. Clinical Infectious Diseases (2020): ciaa530.
  10. Beović M., et al. “Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey”. Journal of Antimicrobial Chemotherapy (2020): dkaa326.
  11. Kim D., et al. “Rates of co-infection between SARS-CoV-2 and other respiratory pathogens”. The Journal of the American Medical Association 323 (2020): 2085-2086.
  12. Winearls S., et al. “Early conscious prone positioning in patients with COVID-19 receiving continuous positive airway pressure: a retrospective analysis”. BMJ Open Respiratory Research 7 (2020): e000711.
  13. Keeley AJ., et al. “Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?” Thorax 75 (2020): 621-622.
  14. Ing AJ., et al. “COVID-19: in the footsteps of Ernest Shackleton”. Thorax 75 (2020): 693-694.
×

Citation

Citation: Igor Klepikov. “Pandemic and Modern Medicine: Time to Recognize and Correct Previous Misconceptions". Acta Scientific Medical Sciences 4.11 (2020): 17-20.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US